Market Overview

UPDATE: Prima BioMed Raises A$1.55M Through Private Placement to Nyenburgh Investment Partners @A$0.05/Share


Prima BioMed Ltd (NASDAQ: PBMD) ("Prima" or the "Company"), a leading immuno-oncology company, announces that it has raised €1M (approx. A$1.55M) via a placement of shares at A$0.05 per share (Placement) to Nyenburgh Investment Partners (NYIP).

Nyenburgh Investment Partners (NYIP), based in the Netherlands, is a specialist healthcare investor. Founded by Alexander Jordaan, Dave van Mastwijk and Ivar van der Salm, NYIP takes long term positions in life sciences companies globally with a specific focus on biotechnology. Further information on NYIP can be found at

The proceeds from the Placement will be used to fund Prima's IMP321 clinical trial program and provide additional working capital.


Related Articles (PBMD)

View Comments and Join the Discussion!

Posted-In: News Financing Offerings Management Insider Trades Press Releases